Financial Services
Live Price
Offline$0.063
+0.00% today
1Y Change
+53.53%
Window
Jun 23, 2025 → Jun 8, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ventana Biotech, Inc. (VNTA) is a Financial Services stock with listed on OTC. The stock last traded around $0.06 and up 53.5% across the available one-year price window (Jun 23, 2025 → Jun 8, 2026). Baseline metrics include revenue growth of +177.0%, EPS growth of +300.0%, a dividend yield of 0.0%. What stands out right now is revenue +177.0%, EPS +300.0%, free cash flow 0.0% with operating margin 88.0% and ROIC 145.5%. Valuation is more restrained than many high-expectation growth names at P/E 23.1 and price/sales 0.9. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines VNTA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VNTA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VNTA Max Drawdown
-56.54%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VNTA and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for VNTA
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.